Tag Archives: SARS

image_pdfimage_print

Cumberland Advisors Market Commentary – COVID-19, SARS, Markets?

Author: David R. Kotok, Post Date: February 21, 2020
Market Commentary - Cumberland Advisors - COVID-19, SARS, Markets

Many market agents have invoked SARS as a model for assessing market strategy and reaction functions to COVID-19. They’re wrong. Here’s a link to the official WHO statistics regarding SARS: “Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003,” https://www.who.int/csr/sars/country/table2004_04_21/en/. Take a look by country and case […]

Cumberland Advisors Market Commentary – Coronavirus #1 with updated death toll

Author: David R. Kotok, Post Date: January 22, 2020
Market Commentary - Cumberland Advisors - Corona Virus & Markets

At Cumberland, we take time to track viral outbreaks for two reasons: (1) Epidemics and pandemics do have market consequences and raise risk, and (2) they can be deadly. SARS, bird flu, Zika, Ebola, and more make the list of outbreaks we have followed closely. In the case of Zika, we wrote a detailed pamphlet […]

SARS Scars

Author: David R. Kotok, Post Date: April 22, 2003

APRIL 21 — The more we hear about SARS the more we get concerned. First, there are continuing deaths and the likelihood is that there will many more in those areas of the world where medical treatment is not as available or comprehensive as in the U.S. Secondly, SARS is increasingly becoming an economic event. […]